Male or female between, and including, 6-12 weeks (42 to 90 days) of age at the time of the first vaccination. 
Subjects for whom the investigator believes that their parents/guardians can and will comply with the requirements of the protocol 
Written informed consent obtained from the parent or guardian of the subject. 
Free of obvious health problems as established by medical history and clinical examination before entering into the study. 
Born after a gestation period between 36 and 42 weeks. 

NCT00344318_inc_T1
Value
between 6-12 weeks
NCT00344318_inc_T2
Value
between 42 to 90 days
NCT00344318_inc_T3
Person
of age
NCT00344318_inc_T4
Temporal
at the time of the first vaccination
NCT00344318_inc_T5
Condition
health problems
NCT00344318_inc_T6
Qualifier
obvious
NCT00344318_inc_T7
Negation
Free
NCT00344318_inc_T8
Value
between 36 and 42 weeks
NCT00344318_inc_T9
Measurement
gestation period
NCT00344318_inc_T10
Condition
Born
NCT00344318_inc_T12
Observation
Written informed consent
NCT00344318_inc_T13
Qualifier
parent
NCT00344318_inc_T14
Qualifier
guardian
NCT00344318_inc_T15
Scope
parent or guardian